What’s Next for Obamacare? by Hilsenrath, Peter E. & O\u27Neill, Liam
University of the Pacific
Scholarly Commons
Eberhardt School of Business Faculty Articles Eberhardt School of Business
1-5-2017
What’s Next for Obamacare?
Peter E. Hilsenrath
University of the Pacific, philsenrath@pacific.edu
Liam O'Neill
University of North Texas Health Science Center
Follow this and additional works at: https://scholarlycommons.pacific.edu/esob-facarticles
Part of the Business Commons, and the Medicine and Health Sciences Commons
This News Article is brought to you for free and open access by the Eberhardt School of Business at Scholarly Commons. It has been accepted for
inclusion in Eberhardt School of Business Faculty Articles by an authorized administrator of Scholarly Commons. For more information, please contact
mgibney@pacific.edu.
Recommended Citation
Hilsenrath, P. E., & O'Neill, L. (2017). What’s Next for Obamacare?. Thrive Global, ,
https://scholarlycommons.pacific.edu/esob-facarticles/123
What’s Next for Obamacare? 
Peter Hilsenrath, University of the Pacific and Liam O’Neill, 
University of North Texas Health Science Center 
The surprising and transformational national election of 2016 has 
left many wondering what is to become of President Obama’s 
signature healthcare reform. Republicans mounted sustained and 
energetic resistance since its inception. But now, they have 
responsibility for what comes next. The US healthcare system is 
widely recognized as both inequitable and inefficient. Obama and 
the Democrats opted to prioritize the former with the Medicaid 
expansion and the health insurance exchanges. Over 20 million 
more Americans are now insured, an achievement Democrats wish 
to preserve. In addition, almost three million young Americans 
under 26 are now covered by their parents’ plan. Republicans will 
not simply end these programs with a return to the 2009 status 
quo. More likely, Medicaid expansion will be reformed, perhaps 
with risk adjusted per capita allocations or block grants as well as 
loosening of state implementation oversight. Funds may be 
distributed more evenly across the states including to those that 
previously opted out, such as Texas and Florida. Coverage may 
become less generous. Blue states with large enrollment gains thus 
far stand to lose the most with reduced federal subsidies. This 
seems unlikely to disturb Republicans very much. Health 
insurance exchanges are already reeling in many states from poor 
design. A death spiral of adverse selection has set in with 
enrollment of high utilization beneficiaries, rising costs and ever 
higher premiums that serve to dissuade relatively healthy 
members from remaining. This drives averages costs and 
premiums even higher. Inadequate penalties for those who choose 
not to sign up through the health exchanges are part of the 
problem but these are more likely to be eliminated than sharply 
increased. According to the IRS, about 7.5 million Americans paid 
an average fine of $200 for not having health insurance in 2014. 
Republicans will probably give insurers a freer hand to set 
premiums based on expected cost. This will allow for more 
attractive premiums for the relatively healthy. Those with chronic 
or pre-existing conditions may be directed to assigned risk pools. 
Health savings accounts are likely to be coupled with high 
deductible policies. These tax advantaged instruments will be 
more beneficial to those with higher incomes. Insurer 
consolidation across state lines can also be expected. Out-of-state 
insurers will find formation of new provider networks difficult but 
acquisition of existing ones may be attractive. 
Obamacare offers less to improve efficiency. But the high 
deductible nature of the exchanges should be welcomed by 
Republicans as a form of consumer-driven health care. Many of 
the innovations in delivery such as Accountable Care 
Organizations that incentivize integration and cost savings will 
likely survive and further develop. Other measures such as a 
powerful federal organization called the Medicare Independent 
Payment Advisory Board, though never formed, is sure to be 
stricken from the books. The Cadillac Tax which imposes a 40 
percent surcharge on rich plans above a threshold and not slated 
to take effect until 2020 will also be a target. It is not popular and 
has already been postponed for two years. On the other hand, 
economists are generally of one mind that tax preferences for 
health insurance leads to over-insurance and excessive healthcare 
expenditures. Republicans may opt to repeal the tax but tinker 
with the exclusion of employer-provided health insurance as 
taxable compensation. 
These and other measures will alter the course of health sector 
development but the landmark nature of Obama’s achievement 
will endure. On the other hand, the greater issue of displacement 
of much of the economy by low productivity health services will 
continue to confound politicians loath to provide leadership about 
what is not worth paying for. An inefficient health sector will still 
sap the growth potential of an already anemic economy. Further 
leadership on the issue remains salient for future elections. 
 
